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Abstract We report eight novel members of the superfamily of
human G protein-coupled receptors (GPCRs) found by searches
in the human genome databases, termed GPR97, GPR110,
GPR111, GPR112, GPR113, GPR114, GPR115 and
GPR116. Phylogenetic analysis shows that these are additional
members of a family of GPCRs with long N-termini, previously
termed EGF-7TM, LNB-7TM, B2 or LN-7TM. Five of the
receptors form their own phylogenetic cluster, while three others
form a cluster with the previously reported HE6 and GPR56
(TM7XN1). All the receptors have a GPS domain in their
N-terminus and long Ser/Thr-rich regions forming mucin-like
stalks. GPR113 has a hormone binding domain and one EGF
domain. GPR112 has over 20 Ser/Thr repeats and a pentraxin
domain. GPR116 has two immunoglobulin-like repeats and a
SEA box. We found several human EST sequences for most
of the receptors showing di¡erential expression patterns, which
may indicate that some of these receptors participate in repro-
ductive functions while others are more likely to have a role in
the immune system.
9 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
The G protein-coupled receptors (GPCRs) are a large fam-
ily of integral membrane proteins that generally act as cell
surface receptors responsible for the transduction of a remark-
able diversity of endogenous signals into a cellular response.
The GPCRs share the same basic molecular architecture with
seven hydrophobic regions of 25^35 consecutive residues. The
de¢ning concept is also that they share a common signalling
mechanism, in that they interact with ubiquitous guanine nu-
cleotide binding regulatory proteins (G proteins) to regulate
the synthesis of intracellular second messengers. The GPCRs
are remarkably diverse at the primary protein sequences, and
that is also re£ected by their diversity in physiological func-
tions. The variety and importance of the physiological roles
undertaken by the GPCR family has resulted in many of their
members becoming important targets for drug development.
Large number of modern drugs are targeted at GPCRs (for
reviews see [1^3]).
The number of known members in the superfamily of
GPCRs is continuously increasing. Some of these include re-
ceptors that have unusually large N-termini with domains
from other well-known proteins. This group of receptors has
been assigned various names, including EGF-TM7 [4] to re-
£ect the presence of epidermal growth factor (EGF) domains
in the N-termini. The subgroup has also been termed B2 [5],
due to some sequence similarity with members of secretin-like
receptors or clan B of GPCRs [1]. Others have called the
group LNB-TM7 [6] or LN-7TM receptors [7]. LN stands
for long N-termini and B denotes the clan. The overall se-
quence similarity between this LN-7TM and clan B is however
fairly low and they di¡er in many aspects. Clan B receptors
bind rather large peptides such as secretin, vasoactive intesti-
nal peptide, pituitary adenylate cyclase-activating polypeptide,
glucagon-like peptide, calcitonin, parathyroid hormone and
corticotropin-releasing factor with a binding unit that consists
of both the N-terminus and other parts of the receptors. The
functional modules that are found in the LN-7TM receptors,
such as EGF, cadherin, lectin, laminin, olfactomedin, immu-
noglobulin or thrombospondin, are not found in clan B re-
ceptors. Initially, it was believed that expression of LN-7TM
receptors was restricted to leukocytes, or other cell types with-
in the immune system. Today, it is well known that a large
range of cell types express these complex molecules. The func-
tional roles of these receptors are still obscure but it has been
suggested, mostly based on tissue distribution and expression
studies, that many of these molecules have a role in the im-
mune system, cell adhesion, cell to cell communications and in
the nervous system.
In this study we created hidden Markov models (HMMs)
based on previously known clan B and LN-TM7 receptors
and searched the human genome database for unique sequen-
ces. We identi¢ed eight new human GPCRs that have struc-
tural similarity to the LN-7TM receptors.
2. Materials and methods
2.1. Identi¢cation of novel receptors
Sequences of known GPCRs from the LN-7TM family were down-
loaded from the NCBI database using the online BLAST and Entrez
tools (http://www.ncbi.nlm.nih.gov/). The sequences were LEC1
(NP_036434.1), LEC2 (NP_055736.1), LEC3 (NP_056051.1), BAI1
(NP_001693.1), BAI2 (NP_001694.1), BAI3 (NP_001695.1), CELSR1
(NP_055061.1), CELSR2 (NP_001399.1), CELSR3 (NP_001398.1),
EMR1 (NP_001965.1), EMR2 (NP_038475.1), EMR3
(NP_115960.1), CD97 (NP_078481.1), ETL (NP_071442.1), HE6
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(NP_005747.1), GPR56 (TM7XN1) (XP_165649.1) and murine Ig-
Hepta receptor (XP_166354.1). We removed the N- and C-terminals,
as identi¢ed by RPS-BLAST searches at http://www.ncbi.nlm.nih.gov/
Structure/cdd/wrpsb.cgi, from these sequences. The truncated receptor
sequences were subsequently aligned using ClustalW 1.81 [8]. From
the alignments, an HMM was constructed using the HMMER 2.2
package [9]. The model was constructed using HMMbuild with de-
fault settings and calibrated using HMMcalibrate. The GeneScan pro-
tein dataset, from assembly 28 of the public human genome sequence,
was downloaded from the NCBI ftp site, ftp.ncbi.nlm.nih.gov/gen-
bank/, and searched against the HMM using HMMsearch, with a
cut-o¡ at E=1e-4. Novel sequences were con¢rmed by searching all
hits against the public databases using the BLAST package [10].
2.2. Identi¢cation of human EST clones
The full genomic DNA sequences of the novel GPCRs were
searched against the human EST database at www.ncbi.nlm.nih.gov/
BLAST/ using BLASTN and against http://genome.ucsc.edu/ using
BLAT with a cut-o¡ at E=1e-12. The alignments with the identi¢ed
expressed sequence tag (EST) sequences were manually inspected to
ensure correct identity.
2.3. Veri¢cation of the predicted coding regions
The machine-predicted coding regions, predicted using GeneScan,
were veri¢ed by assembling the human EST sequences and the full
genomic DNA sequence using SeqMan from the DNASTAR pack-
age. Here, the DNA sequences from the human genome were consid-
ered correct, while the EST and mRNA sequences were used to cor-
rect the predicted exon^intron boundaries. When su⁄cient coverage
could not be obtained by human EST or mRNA sequences a combi-
nation of other vertebrate mRNA and EST sequences as well as the
machine-predicted mouse orthologues from http://genome.ucsc.edu/
were used to verify exon^intron boundaries.
2.4. Phylogenetic analysis
To avoid input order bias, the dataset was randomized 20 times
with regard to sequence input order using a program called Randfasta
(http://www.medfarm.neuro.uu.se/schioth.html). These 20 datasets,
containing the full set of sequences but in di¡erent order, were all
aligned using the UNIX version of ClustalW 1.82 [8]. The default
alignment parameters were applied. The 20 alignments were all boot-
strapped 50 times using SEQBOOT from the Win32 version of the
Phylip 3.6 package [11] to obtain a total of 1000 di¡erent alignments.
Protein distances were calculated using PROTDIST from the Win32
version of the Phylip 3.6 package. The Jones^Taylor^Thornton matrix
was used for the calculation. The trees were calculated on the 20
di¡erent distance matrices, previously generated with PROTDIST,
using NEIGHBOR from the Win32 version of the Phylip 3.6 package,
resulting in 20 ¢les with 50 trees each. The 20 ¢les were merged using
the Gnu UNIX cat command and the resulting ¢le was analyzed using
CONSENSE from the Win32 version of the Phylip 3.5 package to get
a bootstrapped consensus tree. The trees were plotted using TREE-
VIEW (http://taxonomy.zoology.gla.ac.uk/rod/treeview.html). Maxi-
mum parsimony trees were calculated from the same input ¢les that
were used for PROTDIST using PROTPARS from the Win32 version
of the Phylip 3.6 package. The trees were unrooted and calculated
using ordinary parsimony and the topologies were obtained using the
built-in tree search procedure. Consensus trees were calculated and
plotted as described above.
3. Results
Our strategy was to create HMMs and search the human
database for new GPCRs. These search tools are much more
sensitive than for example BLAST and other similar tools as
the models take into consideration information from a group
of proteins and uses a statistical consensus ‘¢ngerprint’ as a
representation of the group of sequences. The new sequences
were not found through previous BLAST searches made by
us, or by others [5], with LN-TM7 receptors. The HMMs
were constructed through alignment of the transmembrane
(TM) regions from a subset of GPCRs, as described in Section
2, and subsequently used to search GeneScan datasets (assem-
bly 28), which were downloaded from the NCBI ftp site at
ftp.ncbi.nlm.nih.gov/genbank/. The search resulted in 25
unique human sequences. Sixteen of those sequences were
identical to known human sequences, while eight were novel.
The sequences were con¢rmed in Celera genome data base
(http://www.celera.com) and all the new sequences were found
there as non-annotated protein sequences, except two that
were only found through HMM searches in the public genome
database. We approached the HUGO Gene Nomenclature
Committee at University College London and they con¢rmed
that the sequences were unique and not public. One of the
sequences, GPR97, had previously been assigned a GPR num-
ber under con¢dentiality to HUGO, by a group unknown to
us. The committee provided the other receptors with new
GPR numbers (GPR110^116) at our request. We subse-
quently made all eight new GPCRs, both protein and DNA
sequences, public through submission to the NCBI database.
It is known that the GeneScan software used for predicting
coding regions for the human genome project has the capacity
to predict approximately 80% of the splice sites correctly [12].
Therefore, we decided to verify the coding regions, to the
extent it could be done, by using mRNA and EST sequences
from a variety of vertebrates, mainly rodents and primates.
The full genomic sequences of the predicted GPCRs were used
as baits to identify mRNA and EST sequences using
BLASTN at www.ncbi.nlm.nih.gov/BLAST/ and BLAT at
http://genome.ucsc.edu/. Below we show the origin and how
each protein was assembled.
GPR97 was identi¢ed in build 28 of the human genome
GeneScan dataset as open reading frame (ORF)
Hs16_10563_28_27_2, and 15 human mRNA sequences were
found for this GPCR. When these mRNAs were assembled, at
least three-fold coverage of the entire coding region was ob-
tained. After editing, the ¢nal coding region of GPR97 was
found to di¡er from the original Hs16_10563_28_27_2 in
several ways. In the N-terminal, which does not start with
a Met, one additional exon of 57 nucleotides was added. At
the seventh splice acceptor, which was found to be wrong,
141 base pairs were added. Also, the last 120 nucleotides
in the C-terminus were replaced by 108 nucleotides from
mRNA sequences, since these 120 nucleotides from
Hs16_10563_28_27_2 were not found to be expressed in any
of the four mRNAs found to cover this region. The mouse
Q9D6B0 sequence is possibly an orthologue to GPR97.
GPR110 was found in the GeneScan dataset with ORF
number Hs6_7559_28_29_4. We identi¢ed 29 di¡erent human
mRNA sequences using Hs6_7559_28_29_4, providing at least
¢ve-fold coverage of the entire coding region. We found that
the third splice site donor was incorrectly predicted by the
GeneScan program, with 42 bp missing, and we added those
from mRNA data to give the complete coding region of
GPR110.
An ORF with number Hs6_7559_28_36_1 was found in the
GeneScan dataset. We could, however, not ¢nd any mRNA
sequences from any species. The mouse genome project has,
on the other hand, a GeneScan-predicted orthologue, which
shows 70% identity at the protein level with a high degree of
third base substitutions, indicating an evolutionary pressure
on this gene. This GPCR was named GPR111.
GPR112 was found as HsX_11876_28_18_4. This is by far
the largest protein found in our searches. We found only one
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human EST clone in the database representing this GPCR.
The putative mouse orthologue is predicted essentially identi-
cally in the mouse genome assembly, but the Celera version of
the human protein is missing the entire N-terminal. We ¢nd it
likely that the Celera version is not correctly predicted since
the N-terminal has a PTX domain as well as a GPS domain,
and a large mucin-like stalk with over 20 glycosylation sites.
Also the N-terminal consists largely of one ORF, over 2000
amino acids long.
GPR113 was identi¢ed in build 28 of the human genome
with ORF number Hs2_30849_28_3_1. Two human EST se-
quences were found from this receptor, covering approxi-
mately 40% of the coding region, showing that the ¢fth splice
site were predicted incorrectly, with 27 bases missing at the
donor site, which was subsequently added from the mRNA
sequences. The machine-predicted sequences of the mouse
orthologues from the mouse genome project at http://
genome.ucsc.edu/ were found to be identical, providing some
evidence for the correctness of the rest of the splice sites.
GPR114 was found as ORF Hs16_10563_28_29_ 3. It has
relatively few mRNA sequences in the database, which may
indicate low or specialized expression. We found EST sequen-
ces covering the third splice site, which was not predicted
correctly in the machine-predicted sequence, and the missing
sequence was added from EST data. In total approximately
50% of the protein has EST coverage.
GPR115 was found as ORF Hs6_7559_28_36_2. Approxi-
mately 45% of the coding region was covered by EST sequen-
ces. We found an error in the machine-predicted coding re-
gion in the second last splice site. Here, 154 amino acids were
missing and these were added from the EST data. However,
we found no EST or mRNA sequences covering the N-termi-
nal region.
GPR116 was identi¢ed as the non-annotated sequence
XP_166354.1. It is likely to be the human orthologue of the
rat Ig-Hepta receptor [13], since they share 72% sequence
identity at the amino acid level. We have, however, chosen
to give this GPCR the name GPR116, because the ortholo-
gous^paralogous relationship between these receptors is at
present unclear and it could cause important confusion if
we were to assign it wrongly. The machine-predicted sequence
of XP_166354.1 was found to be represented by three di¡erent
and partial mRNAs, which when assembled provided a full
coverage of the coding region. The original XP_166354.1 se-
quence was found to di¡er from the mRNA sequences at the
fourth splice acceptor where 402 nucleotides were missing
from XP_166354.1. This sequence was added from the con-
sensus mRNA sequence, and the exon/intron organization of
the ¢nal sequence of GPR116 was found to correspond ex-
actly to the published mRNA of rat Ig-Hepta [13].
A summary of the results are found in Table 1, where we
list the name, accession numbers, chromosomal positioning,
GeneScan ORF numbers, number of exons, length in amino
acids, and tissue distribution as suggested by EST data. Fig. 1
shows alignment of the TM regions of the eight new GPCRs
together with two of the previously known LN-7TM recep-
tors, GPR56 (TM7XN1) [7] and HE6 [14]. Fig. 2 shows phy-
logenetic analyses, using maximum parsimony, of LN-7TM
receptors together with the new receptors we report here.
The topology of the tree is largely identical using distance
methods (data not shown). Considering this dataset, boot-
strap values show ¢ve small groups with very high bootstrapT
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support. Phylogenetic analysis of the LN-7TM receptors with
other GPCRs (from clans A, B and C) shows that these are
evolutionarily distant from the LN-7TM receptors (data not
shown). Looking at Fig. 2, and following the clusters in anti-
clockwise manner, the ¢rst group consists of GPR56 and HE6
together with three of our new GPCRs, GPR97, GPR112 and
GPR114 (bootstrap: 952 of 1000). The second group consist
of three BAI proteins (bootstrap: 966), while the third group
includes ¢ve of the new GPCRs, GPR113, GPR116, GPR110,
GPR115 and GPR111 (bootstrap: 966). The fourth group
consists of three CELSR proteins (bootstrap: 962), while
CD97, three EMR proteins, ETL and three LEC proteins
form the ¢fth group (bootstrap: 817). It should be mentioned
that we opted to show the phylogenetic analysis of the trun-
cated receptors, i.e. only covering the region from the start of
TM1 to the end of TM7. This because it is evident that the
proteins in this family are composed of units with di¡erent
evolutionary origin since the domains in N-termini are derived
from other di¡erent types of proteins. We did not ¢nd any
phylogenetic relationship between the N-terminals of these
new receptors and any other GPCR beyond the domains
that are shown in Fig. 3.
The domains in the N-terminal regions in all of the new
receptors were identi¢ed using RPS-BLAST at NCBI and
HMM domain search at Celera, with the full-length GPCR
sequences as query, with the default settings (see Section 2).
These search engines predicted the same domains, with excep-
Fig. 2. Phylogenetic analysis of the new human GPCRs with other
human LN-7TM receptors using the regions from TM1 to the end
of TM7, obtained by maximum parsimony analysis (Phylip 3.6).
The numbers above the nodes indicate percentage of bootstrap rep-
licates. The accession numbers are listed in Table 1.
Fig. 1. Amino acid sequence alignment of the region from TM1 to TM7 of the novel human GPCRs, HE6 and GPR56 made using ClustalW
(1.82) software and edited by manual inspection. The lines mark putative TM regions, and gray boxes indicate conserved sequence motifs. The
accession numbers are listed in Table 1.
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tion of the EGF domain in GPR113, which was not predicted
by NCBI’s RPS BLAST.
Below we list the human EST hits we found for each new
GPCR, listing ¢rst the name of the receptor ; accession number
(tissue). GPR97 : 601809910F1 (lung, carcinoma), AGEN-
COURT_7785691 (lung, carcinoma), TCAAP1D6491 (pe-
diatric acute myelogenous leukemia cell), TCAAP1D4626
(pediatric acute myelogenous leukemia cell), AGEN-
COURT_7828938 (lung, carcinoma), TCAAP1E4365 (pedia-
tric pre-B cell acute lymphoblastic leukemia), TCAAP1E0686
(pediatric acute myelogenous leukemia cell), AGEN-
COURT_7587954 (lung, carcinoma), IL3-MT0267-120101-
445-H10 (marrow, adult), hf44e05.x1 (fetal lung NbHL19W,
testis NHT, and B-cell NCI_CGAP_GCB1, pooled),
wf37e09.x1 (fetal lung NbHL19W, testis NHT, and B-cell
NCI_CGAP_GCB1, pooled), TCAAP1E14475 (pediatric
acute myelogenous leukemia cell), RC0-MT0059-200600-021-
a08 (marrow, adult), PM1-MT0429-200601-009-e07 (marrow,
adult), QV1-MT0166-131100-483-g04 (marrow, adult).
GPR110 : 601646506F1 (prostate), xt19d07.x1 (uterus),
K-EST0058804 (myeloma), 602492853F1 (kidney), PM1-
BN0083-030300-003-h10 (breast_normal), MR3-AN0025-
080800-006-g06 (amnion_normal), MR3-AN0025-080800-
006-f06 (amnion_normal), MR3-AN0025-250700-001-d12
(amnion_normal), MR3-AN0025-030800-003-b05 (amnion_-
normal), ob20b09.s1 (kidney), MR3-AN0025-070800-006-d03
(amnion_normal), IL2-FT0167-070800-123-A09 (prostate_tu-
mor), IL2-FT0167-070800-123-A02 (prostate_tumor),
xn18g09.x1 (kidney), MR3-AN0025-030800-003-b08 (am-
nion_normal), oj15a02.y5 (kidney), hr84a09.x1 (kidney),
QV2-BT0616-061200-518-e11 (breast), 602330074F1 (pros-
tate), hw29c08.x1 (kidney), QV4-BN0090-270400-190-h10
(breast_normal), tm56f05.x1 (kidney), K-EST0127034 (myelo-
ma), UI-CF-EN1-adg-c-13-0-UI.s1 (lung), UI-H-BI2-agb-c-
2435
705
405
215
188
Fig. 3. A: Amino acid sequence alignment of the GPS (Gpcr Proteolytic Site) domain in the novel human GPCRs, HE6 and GPR56 made us-
ing ClustalW (1.82) software and edited by manual inspection. The residues in black are conserved through all receptors, while the gray boxes
indicate highly conserved sequence motifs. B: Amino acid sequence alignment of the hormone binding domain (HBD) in GPR113 with the
HBD in LEC1^3 and PTH2 receptors made using ClustalW (1.82) software and edited by manual inspection. The residues in black are con-
served through all receptors. C: Schematic presentation of the domains found in the N-termini. The GPS, EGF, HBD, C2 (C2-set immuno-
globulin), SEA (sperm protein, enterokinase, and agrin) and PTX (pentraxin) domains are shown as boxes in black and gray while glycosyla-
tion sites (NXS or NXT tripeptide sequences that conform to the consensus sequence for N-linked glycosylation) are shown as small circles
attached to the N-terminal stretches. The numbers at the end of each N-terminus are the numbers of amino acids found in the N-termini from
the predicted start at TM1.
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12-0-UI.s1 (kidney), wv02e11.x1 (kidney), 602499188F1 (kid-
ney), tw54b05.x1 (uterus). GPR111 : none. GPR112 :
ab03a10.r1 (fetal retina). GPR113 : zu91g01.s1 (testis),
603252694F1 (testis), zu91g02.s1 (testis). GPR114 :
TCAAP1E4325 (pediatric pre-B cell acute lymphoblastic leu-
kemia), TCAAP1Q15716 (pediatric acute myelogenous leuke-
mia cell (FAB M1), 602715392F1 (primary B cells from ton-
sils (cell line)), TCAAP4E0527 (pediatric acute myelogenous
leukemia cell), 603061618F1 (leukocyte), ie67d12.y3 (pancreas
islets of Langerhans), CM4-HT0509-110200-095-e09 (head_-
neck, adult), TCAAP2E5094 (pediatric acute myelogenous
leukemia cell). GPR115 : zl16a07.r1 (uterus, pregnant),
zk69a02.r1 (uterus, pregnant), zk27g08.r1 (uterus, pregnant),
zk25b11.r1 (uterus, pregnant), PM2-BN0063-210200-003-d06
(breast_normal), hh70c04.y1 (genitourinary tract). GPR116 :
602591049F1 (lung), 602464465F1 (kidney), AL551728 (pla-
centa), zb53f09.r1 (fetal lung), za74b06.r1 (fetal lung), CM0-
NT0186-181100-711-a12 (nervous_tumor), 602501038F1 (kid-
ney), AV725650 (hypothalamus), 602465931F1 (kidney),
MR3-CT0465-300800-005-d12 (colon), 603180744F1 (brain),
602564677F1 (lung), MR3-CT0465-300800-005-d12_1 (colon),
ya86g04.r1 (fetal spleen), UI-E-EO0-aia-h-11-0-UI.r1 (fetal
eye), 602589054F1 (liver), 601861084F1 (lung), IL2-HT0436-
250300-044-E09 (head_neck), wn20a12.x1 (stomach),
zd24e12.r1 (fetal heart), yj67g03.r1 (breast), UI-H-EZ1-bbe-
j-13-0-UI.s1 (left pelvis), xf49h02.x1 (stomach), AV658066
(non cancerous liver tissue), 602017176F1 (brain),
yp77c12.r1 (fetal liver spleen), yf43g04.r1 (fetal liver spleen),
cp3149.seq.F (human fetal heart), EST66136 (kidney),
603201927F1 (testis), KIAA0757 (brain), AB018301.
4. Discussion
Phylogenetic analysis of the new GPCRs shows that they
belong to the family of LN-7TM receptors. The overall phy-
logenetic analysis of the LN-7TM family shows that there
exist at least ¢ve di¡erent groups of LN-7TM receptors
(named by us groups 1^5, see Fig. 2). Three of the new re-
ceptors show high bootstrap values to group them closely to
the previously known HE6 and GPR56 (group 1). Interest-
ingly, the other ¢ve receptors form a group of their own
(group 3). The high bootstrap values for each of the groups
indicate that the receptors that we have assigned to each
group are likely to share a common ancestor.
The overall sequence identity among the receptors within
groups 1 and 3 is about 28^30% and 45^50% in the TM
regions. This is relatively low as compared with for example
many of the subgroups of rhodopsin receptors. The well
studied monoamine (adrenergic, histamine, serotonin, etc.)
and peptidergic (neuropeptide Y, melanocortin, cholecystoki-
nin, etc.) receptors have about 45^60% sequence identity in
the TM1 to TM7 region and as high as 60^80% in the TM
regions. It is, however, evident that there are some highly
conserved features within both groups 1 and 3, indicating
that there exists a speci¢c evolutionary pressure on their pri-
mary structures, also in the TM regions. There is a highly
conserved region in TMIII, including a conserved Trp-Met
motif, and another conserved region with a Trp in TMVI
(see conserved regions denoted in gray in Fig. 1). There are
also conserved regions in TMVII, where all the receptors ex-
cept GPR114 have Glu positioned in the middle of the TM
region. A conserved region in TMIV shows a clear distinction
between groups 1 and 3, where group 1 has conserved hydro-
phobic Trp in a position where group 3 has conserved hydro-
philic Tyr. This region also includes a Pro, a residue known to
cause kinks in K-helices, which is conserved through both
groups [3]. Alignment of the new receptors with some classical
clan B receptors (such as the secretin receptor) indicates that
these Trp residues in TMIII, TMIV and TMVI are widely
found in these receptors (data not shown). Another conserved
property in this part of the receptors is Cys residues in the
putative extracellular loop 2 and extracellular loop 3. This is a
feature that is widely found in the superfamily of GPCRs.
There is strong evidence that these residues form a disul¢de
bridge between these loops and that they are important for
the structural integrity of the protein as shown by studies on
rhodopsin GPCRs [3].
We searched the protein sequences for functional domains
using the NCBI and Celera search tools. The TM domains are
proposed to be of type 2 (clan B or secretin-like) in both
search machines. It should, however, be noted that the LN-
7TM family does not yet have a speci¢c designated domain
search tool at either NCBI or Celera. The domains that were
found in the N-termini of the ¢ve new receptors together with
HE6 and GPR56 are shown in Fig. 3. All the new GPCRs
have a GPS (Gpcr Proteolytic Site) domain close to the TM
regions. The GPS domains are found in all LN-7TM receptors
but they are not found in any of the clan B receptors, or any
other GPCR as far as we are aware of, but they are found in
other types of receptors [15]. One of the LN-7TM receptors,
CL1 (LEC1), is shown to be endoproteolytically cleaved at the
end of the GPS domain resulting in two subunits that remain
non-covalently associated as a heterodimer [15,16]. No clear
functional role has yet been ascribed to the GPS. The GPS
region in our new receptors has four conserved Cys, two con-
served Trp, one conserved Phe, and a number of other resi-
dues that are conserved in almost all the receptors (see Fig. 2).
It is possible that variation in the sequence in this region has a
role as alternative cleavage site for the di¡erent receptors that
may a¡ect their functional roles. The N-terminals of the re-
ceptors do not show any other speci¢c region with high se-
quence similarities that are shared through all the receptors in
either group 1 and 3. Another feature that is shared by all the
new receptors is Ser/Thr-rich regions, or multiple repeats of
glycosylation sites forming what have also been termed mu-
cin-like stalks. The N-termini of all the new receptors are
virtually made up of these stalks. One of the receptors,
GPR113, has one EGF domain at the end of the N-terminus
(see Fig. 3). The EGF domain is characterized by a set of six
conserved Cys residues that typically form disul¢de bonds in a
1^3, 2^4, 5^6 arrangement and are often found in connective
tissue proteins such as ¢brillins and ¢bulins [17]. GPR113 thus
shows a structural similarity to the group of EMR receptors,
ETL and CD97 found in group 2 (see Fig. 2) that have multi-
ple EGF domains in their N-termini. The EGF-TM7 recep-
tors are predominantly expressed in myeloid cells (EMR1,
EMR2, EMR3, and CD97) and smooth muscle cells (ETL
and CD97). It has been suggested that these receptors partic-
ipate in cellular functions of myeloid leukocytes and cardiac
muscle di¡erentiation by interacting with other cell surface
proteins or extracellular matrix proteins. Recently, it was
demonstrated that CD97 interacts with a de¢ned cellular li-
gand, CD55 (decay-accelerating factor) solely by the EGF-like
domains [18].
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GPR113 also has a sequence termed ‘hormone binding do-
main’ within its N-terminus. Hormone binding domains are
found in many hormone binding receptors, including many of
the clan B receptors and some of the LN-7TM receptors, such
as LEC and BAI. The four hormone binding domains that are
most related to the one in GPR113 are shown in Fig. 3. The
hormone binding domain in LEC3 receptor (latrophilin-3)
shows the closest similarity but the hormone binding domain
in the clan B PTH2 receptor also shows clear similarity. There
are nine conserved residues in these ¢ve receptors: two con-
served Cys, which may form disul¢de bridges, two Pro, two
Trp and three Gly. There is, however, low similarity between
the other residues in this putative domain.
GPR112 also has an interesting domain in the N-terminus
or a PTX (pentraxin) domain. The closest hit by BLAST with
the PTX domain in GPR112 is the neuronal pentraxin II
precursor (NP-II). The pentraxins (earlier also termed pentax-
ins) are evolutionarily highly conserved proteins that have up
to ¢ve non-covalently bound identical subunits that are ar-
ranged in a £at pentameric disk. Many of them are cytokine-
inducible acute phase proteins and some have been implicated
in inherited immunity and Alzheimer’s disease. C reactive
protein and serum amyloid P component are short pentraxins,
whose concentrations in the blood increase dramatically upon
infection or trauma [19]. We are not aware of other GPCRs
that have a PTX domain. The N-terminus of GPR112 is ex-
tremely long, about 2400 residues. This is slightly shorter than
the longest LN-7TM receptors, CELSR (cadherin, EGF LAG
seven-pass G-type receptor), which have up to 2500 residues
in their N-termini. It is also much longer than for the most of
the other receptors in this phylogenetic cluster. The new re-
ceptors we present here are otherwise among the shortest
within the group of LN-7TM receptors. It is remarkable
that the entire region spanning from the GPS domain to the
PTX domain has a number of Ser/Thr glycosylation sites in-
dicating that this long N-termini forms a long stalk that erects
from the cell with the PTX domain at its end.
GPR116 has two C2-set immunoglobulin superfamily do-
mains. These immunoglobulin-like repeats are characteristic
motifs for the members of the immunoglobulin superfamily
of cell surface proteins [20]. GPR116 also has a SEA box
more distal in the N-terminus. The SEA box was ¢rst de-
scribed as a motif present in an ectodomain of a number of
mucin-like membrane proteins. It was named after the ¢rst
three proteins in which it was ¢rst identi¢ed (sperm protein,
enterokinase, and agrin). There are several proteins that have
a SEA box, whose function, however, is not entirely clear. Its
likely function is to serve as a site for proteolytic cleavage [21].
As mentioned in Section 3, GPR116 is possibly the human
orthologue of the Ig-Hepta previously cloned in rats and mice
[22]. Ig-Hepta is predominantly expressed in the lung, but also
in the kidney, and it has been suggested that Ig-Hepta may be
involved in pH sensing or pH regulation [13].
The other new GPCRs, GPR97, GPR110, GPR111,
GPR114, and GPR115, like the previously cloned HE6 and
GPR56, do not have any clear domains beyond the GPS
domain that is recognizable with the above-mentioned search
tools. It is likely that these receptors have functional domains
that we have not yet identi¢ed. Their mucin-like stalks indi-
cate that they indeed have functional units in their N-termini,
and these could contain amino acid stretches that only recog-
nize speci¢c molecules. It is possible that such domains can
only be identi¢ed through functional assays. Phylogenetic
analysis of these receptors in more distant species, when
such sequences become available, may reveal which speci¢c
regions are evolutionarily conserved and thus more likely to
be of functional importance.
The tissue expression pattern that can be seen in the EST
data is variable for the new receptors. GPR110, GPR114,
GPR116 and GPR117 are found in multiple tissues with a
number of EST hits. Some of the other receptors seem to
have a more de¢ned expression pattern perhaps indicating a
tissue-speci¢c function. GPR113, the one with a hormone
binding and an EGF domain, seems to have its expression
restricted to testis. GPR115 also seems to have an expression
pattern that could match a protein that has a role in repro-
duction. GPR110 and GPR111 are also expressed in organs
that participate in reproduction, while they are also found in
other tissues such as the lung, which is one of the major
expression sites for the LN-7TM receptors with EGF do-
mains. The expression of the other receptors, that we found
EST sequences for indicates a rather broad expression pattern,
including many of the tissues in which the other members of
the LN-7TM receptors have previously been found to be ex-
pressed.
In summary, we have identi¢ed eight new GPCRs that be-
long to the LN-7TM subgroup of receptors. Several of these
receptors have functional domains in their N-termini such as
GPS, EGF, SEA box, PTX and immunoglobulin domains
that may provide indications of their functional role. The
expression patterns of some of the receptors indicate that
they may participate in reproductive functions, while others
are likely to have a role in the immune system like many other
LN-7TM receptors.
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